Tidepool completes FDA 510(k) submission of Tidepool Loop
If cleared, Tidepool Loop could become the first app for iOS cleared for the automatic dosing of insulin.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 21
If cleared, Tidepool Loop could become the first app for iOS cleared for the automatic dosing of insulin.
14 Dec 20
The partnership is expected to reduce the burden for people with diabetes in daily therapy management and improve…
Control-IQ technology uses Dexcom G6 CGM values to predict glucose levels 30 minutes ahead and adjust insulin delivery…
25 Nov 20
The medical devices used to manage diabetes largely depend on the severity of the condition, whether it's the…
20 Nov 20
Lilly will commercialise an insulin delivery system, which features an insulin pump developed and manufactured by Ypsomed
16 Nov 20
The integrated system delivers real-time glucose readings, as well as insulin dose information for users
27 Oct 20
The collaboration between Drawbridge Health and Sumitomo Dainippon Pharma will focus initially on the development of a biomarker…
09 Oct 20
Lark will use the funding to expand its relationship with Anthem-affiliated health plans and deploy AI powered platform…
08 Oct 20
Companies will partner to promote Lyumjev, Lilly's new rapid-acting insulin, with Dexcom G6 Continuous Glucose Monitoring (CGM), highlighting…
GlobalData expects the global insulin pen market to grow at a rate of 2.3% - compared to the…